Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
Reuters·2025-11-06 21:49A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 billion battle with U.S. rival Pfizer to win Metsera's obesity drug assets. ...